These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7634262)

  • 21. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Pan JH; Sukhova GK; Yang JT; Wang B; Xie T; Fu H; Zhang Y; Satoskar AR; David JR; Metz CN; Bucala R; Fang K; Simon DI; Chapman HA; Libby P; Shi GP
    Circulation; 2004 Jun; 109(25):3149-53. PubMed ID: 15197138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased platelet deposition on atherosclerotic coronary arteries.
    van Zanten GH; de Graaf S; Slootweg PJ; Heijnen HF; Connolly TM; de Groot PG; Sixma JJ
    J Clin Invest; 1994 Feb; 93(2):615-32. PubMed ID: 8113399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries.
    Llorente-Cortés V; Otero-Viñas M; Berrozpe M; Badimon L
    Eur J Clin Invest; 2004 Mar; 34(3):182-90. PubMed ID: 15025676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue factor in the pathogenesis of atherosclerosis.
    Taubman MB; Fallon JT; Schecter AD; Giesen P; Mendlowitz M; Fyfe BS; Marmur JD; Nemerson Y
    Thromb Haemost; 1997 Jul; 78(1):200-4. PubMed ID: 9198153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.
    Naito M; Stirk CM; Smith EB; Thompson WD
    Thromb Res; 2000 Apr; 98(2):165-74. PubMed ID: 10713318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept.
    van der Wal AC; Becker AE; van der Loos CM; Tigges AJ; Das PK
    Coron Artery Dis; 1994 Jun; 5(6):463-9. PubMed ID: 7952404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells].
    Naito M
    Nihon Ronen Igakkai Zasshi; 2000 Jun; 37(6):458-63. PubMed ID: 10998926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen and smooth muscle cell detection in atherosclerotic plaques from stable and unstable angina -- an immunohistochemical study.
    Loukas M; Dabrowski M; Wagner T; Walczak E; Witkowski A; Ruzyłło W
    Med Sci Monit; 2002 Apr; 8(4):BR144-8. PubMed ID: 11951060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Introductory review of diagnostic approach to arteriosclerosis].
    Yoshimura M; Sakurabayashi I
    Rinsho Byori; 1998 Jul; 46(7):663-5. PubMed ID: 9721532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipids and atherosclerosis].
    Gmiński J
    Wiad Lek; 1996; 49(7-12):153-8. PubMed ID: 9245111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular mechanisms of atherogenesis.
    DiCorleto PE
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):314S-318S. PubMed ID: 8297538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen/fibrin in atherogenesis.
    Smith EB; Thompson WD; Crosbie L; Stirk CM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New aspects on the etiology and pathogenesis of arteriosclerosis from the pathologic viewpoint].
    Constantinides P
    Z Gesamte Inn Med; 1988 May; 43(10):257-61. PubMed ID: 3046156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The cellular-molecular aspects of experimental atherosclerosis in rabbits. The characteristics of the development of initial atherosclerotic lesions in the aorta].
    Nagornev VA; Mal'tseva SV
    Arkh Patol; 1993; 55(2):64-9. PubMed ID: 7980066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of caveolae in cholesterol transport in arterial smooth muscle cells exposed to lipoproteins in vitro and in vivo.
    Thyberg J; Calara F; Dimayuga P; Nilsson J; Regnström J
    Lab Invest; 1998 Jul; 78(7):825-37. PubMed ID: 9690560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
    Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
    J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina.
    Smith EB
    Eur Heart J; 1990 Aug; 11 Suppl E():72-81. PubMed ID: 2226536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.